Chapter 44 ■ Exchange Transfusions 317
(2) Blood may be anticoagulated with citrate phosphate dextrose (CPD or CPDA1) or heparin
(heparinized blood is not licensed for use in the
United States). Additive anticoagulant solutions
are generally avoided; if there is no other option,
packed red cells stored in additive solutions may
be washed or hard packed prior to reconstitution
(3) Hematocrit (Hct) may be adjusted within the
range of 45% to 60%, depending on desired end
(4) Blood should be as fresh as possible (<7 days)
(5) Irradiated blood is recommended for all ET to
prevent graft-versus-host disease. There is a significant increase in potassium concentration in
stored irradiated units, so irradiation should be
performed as close to the transfusion as possible
(6) Standard blood-bank screening is particularly
important, including sickle cell preparation, HIV,
(7) Donor blood should be screened for G-6-PD
deficiency and HbS in populations endemic for
(1) If delivery of an infant with severe HDN is
anticipated, O Rh-negative blood cross-matched
against the mother may be prepared before the
(2) Donor blood prepared after the infant’s birth
should be negative for the antigen responsible
for the hemolytic disease and should be crossmatched against the infant.
(3) In ABO HDN, the blood must be type O and
either Rh-negative or Rh-compatible with the
mother and the infant. The blood should be
washed free of plasma or have a low titer of antiA or anti-B antibodies. Type O cells may be used
with AB plasma, but this results in two donor
(4) In Rh HDN, the blood should be Rh-negative
and may be O group or the same group as the
c. In infants with polycythemia, the optimal dilutional
fluid is isotonic saline rather than plasma or albumin (26).
Volume of Donor Blood Required
a. Whenever possible, use no more than the equivalent of one whole unit of blood for each procedure,
b. Quantity needed for total procedure = volume for
the actual ET plus volume for tubing dead space
No comments:
Post a Comment